Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Ischemia Modified Albumin In Diagnosing Ischemic New Events (IMAGINE Study).

NCT00355992 is registered in ClinicalTrials.gov with Inverness Medical Innovations as lead sponsor.

NCT NCT00355992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00355992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Ischemia Modified Albumin In Diagnosing Ischemic New Events (IMAGINE Study).
Lead sponsor
Inverness Medical Innovations
Phase
Observational
Overall status
Terminated
Start date
September 30, 2006
Completion date
December 31, 2007
Enrollment
1,250 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

heart disease, ischemic, ischemia, myocardial, ischemic heart disease, unstable angina